Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$2.2MFederal grants as PI2 awards
0Patents grantedNone matched
67Papers1,934 citations
Federal awards and patents by year
AwardsPatents
2 awards · $2.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 22, 2017 | NIH | SBIR Phase II Development of an LXR agonist as first in class therapy for treatment of metastatic melanoma | $521K | RGENIX, INC. |
| Sep 1, 2016 | NIH | SBIR Phase II Development of an LXR agonist as first in class therapy for treatment of metastatic melanoma | $1.6M | RGENIX, INC. |
1 patents as inventor
- US RGENIX, INC.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#923
Awards as PI#1,252
Patents#273
Companies
- RGENIX, INC.Leads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.